Stryker Corporation (LON:0R2S)
London · Delayed Price · Currency is GBP · Price in USD | Market Cap | 109.00B |
| Revenue (ttm) | 17.38B |
| Net Income (ttm) | 2.13B |
| Shares Out | n/a |
| EPS (ttm) | 5.51 |
| PE Ratio | 51.18 |
| Forward PE | 26.50 |
| Dividend | 2.53 (0.63%) |
| Ex-Dividend Date | Jun 30, 2025 |
| Volume | 373 |
| Average Volume | 279 |
| Open | 380.94 |
| Previous Close | 399.49 |
| Day's Range | 370.20 - 382.54 |
| 52-Week Range | 315.97 - 406.70 |
| Beta | 0.99 |
| RSI | 37.24 |
| Earnings Date | Jul 31, 2025 |
About Stryker
Stryker Corporation operates as a medical technology company. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke,... [Read more]
Financial Performance
In 2024, Stryker's revenue was $22.60 billion, an increase of 10.23% compared to the previous year's $20.50 billion. Earnings were $2.99 billion, a decrease of -5.43%.
Financial numbers in USD Financial StatementsNews
10 stocks favored to gain up to 30% in a sector that has missed this year's rally
All but two of the S&P 500's sectors are up so far in 2025.
Inari Medical, now part of Stryker, launches the all-new InThrill® Thrombectomy System, designed to address arteriovenous access and small vessel thrombus cases
PORTAGE, Mich. , July 29, 2025 /PRNewswire/ -- Inari Medical, now part of Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of its next-generation InThrill Thrombectom...
Rep. Thomas Kean Has Sold Up to $65K Worth Of Stryker Stock: Here's What You Should Know
A July filing shows that Representative Thomas Kean reported a sale in Stryker (NYSE: SYK), valued between $16,002 and $65,000. The transaction date is listed as June 26, 2025, with the report publis...
Looking Into Stryker's Recent Short Interest
Stryker's (NYSE: SYK) short percent of float has risen 12.86% since its last report. The company recently reported that it has 5.74 million shares sold short , which is 1.58% of all regular shares th...
North America Cystoscopes Market Outlook Report 2025-2033 Featuring Key Companies - Olympus, KARL STORZ, Stryker, PENTAX Medical, Richard Wolf, Ambu, Laborie Medical Technologies
Discover comprehensive insights with the "North America Cystoscopes Market Outlook to 2033" report. Analyze market data, company shares, and segment details for Flexible and Rigid Cystoscopes. Develop...
Cathie Wood Vs. Jim Cramer: TV Host Says Top Ark AI Pick 'Losing Money Hand Over Fist'
When it comes to artificial intelligence stocks , there are multiple that are found in the various portfolios of Ark Funds, led by Cathie Wood. One of Wood's favorite AI stocks has been criticized by ...
Here's How Much You Would Have Made Owning Stryker Stock In The Last 5 Years
Stryker (NYSE: SYK) has outperformed the market over the past 5 years by 2.18% on an annualized basis producing an average annual return of 16.79%. Currently, Stryker has a market capitalization of $...
Stryker to announce financial results for its second quarter of fiscal year 2025
Portage, Michigan, July 01, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for its second quarter of fiscal year 2025 on Thursday, July 31, 2025. A press ...
US stocks threatens to close at record levels but closes just off record levels
The broader stock indices threatened to close at record levels with the S&P index getting within one point of a record high level. The comes in at 6147.43. The high price today reached 6146.52. The NA...
The Big 3: NXT, ANET, SYK
Today's trading action added confidence to Dan Deming's perception on the markets, noting widening market breadth as a healthy sign for price action. On individual stocks, he sees growth opportunities...
Stryker receives FDA clearance for Incompass Total Ankle System
PORTAGE, Mich.--(BUSINESS WIRE)--Stryker received FDA 510(k) clearance for its Incompass® Total Ankle System, intended for patients with severe arthritis-related ankle joint damage.
Stryker: Solid Growth And Improving Margins Continue To Drive The Stock Higher
How Do Investors Really Feel About Stryker?
Stryker's (NYSE: SYK) short percent of float has risen 5.1% since its last report. The company recently reported that it has 5.99 million shares sold short , which is 1.65% of all regular shares that...
The 3 Most Overvalued Stocks Top Managers Are Selling in 2025
The best fund managers are scaling back in these expensive stocks this year. 00:00 Introduction 00:39 Netflix NFLX 01:23 Mastercard MA 02:07 Stryker SYK Susan Dziubinski: I'm Susan Dziubinski with Mor...
Here's How Much $1000 Invested In Stryker 20 Years Ago Would Be Worth Today
Stryker (NYSE: SYK) has outperformed the market over the past 20 years by 2.57% on an annualized basis producing an average annual return of 10.84%. Currently, Stryker has a market capitalization of ...
Stryker gets FDA clearance for its OptaBlate system
Stryker's OptaBlate system gains FDA clearance, offering a minimally invasive solution for long-lasting relief from vertebrogenic pain. Read more here.
Stryker receives FDA clearance for OptaBlate® BVN Basivertebral Nerve Ablation System
Stryker's first basivertebral nerve ablation system targets the basivertebral nerve to provide relief from chronic* vertebrogenic low back pain. PORTAGE, Mich.
Recent Filing Shows That Rep. Thomas Kean Bought Over $9K Worth of Amazon.com Stock
A May filing shows that Representative Thomas Kean reported a purchase in Amazon.com (NASDAQ: AMZN), valued between $9,009 and $135,000. The transaction date is listed as May 15, 2025, with the repor...
Baron Opportunity Fund Q1 2025 Top Contributors And Detractors
xAI Holdings led performance, driven by rapid AI innovation, Grok 3 launch, and the strategic acquisition of X, enhancing data access and integration. Spotify delivered strong results with margin expa...
Stryker Corporation (SYK) Bank of America Securities 2025 Global Healthcare Conference (Transcript)
SA analyst downgrades: PLTR, NEM, USB, SYK, DXCM, BK, ZIM, GERN
Seeking Alpha analysts have issued stock rating downgrades for PLTR, NEM, USB, SYK, DXCM, BK, ZIM, GERN, BMBL, BLDR, QTWO, SAR and VNO. Read more here.
Stryker: Mako Spine And Shoulder Launching Is On Track (Downgrade To Hold)
Ronda E Stryker Takes Money Off The Table, Sells $75.39M In Stryker Stock
Ronda E Stryker , Director at Stryker (NYSE: SYK), executed a substantial insider sell on May 8, according to an SEC filing. What Happened: Stryker's decision to sell 200,000 shares of Stryker was re...
Stryker declares an $0.84 per share quarterly dividend
Portage, Michigan, May 08, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.84 per share payable July 31, 2025, to shareholders...
Here's How Much $100 Invested In Stryker 10 Years Ago Would Be Worth Today
Stryker (NYSE: SYK) has outperformed the market over the past 10 years by 4.9% on an annualized basis producing an average annual return of 15.23%. Currently, Stryker has a market capitalization of $...